| Dr George E Fahy Iii, MD | |
|
2004 Medical Center Dr, Bay Minette, AL 36507-4163 | |
| (251) 937-2380 | |
| (251) 937-7841 |
| Full Name | Dr George E Fahy Iii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 2004 Medical Center Dr, Bay Minette, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578586798 | NPI | - | NPPES |
| 160059682 | Other | RAILROAD RETIRE PROV NUMB | |
| 51510969 | Other | AL | BCBS PROVIDER NUMBER |
| 630438739007 | Other | CHAMPUS PROVIDER NUMBER | |
| 009994760 | Medicaid | AL |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Baldwin Infirmary | Bay minette, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Imc North Baldwin Physician Group Llc | 8426307729 | 2 |
News Archive
Marking the start of Antibiotic Awareness Week, NPS MedicineWise is urging all health professionals to pledge their commitment to preserve the miracle of antibiotics and re-shape consumer expectations of these lifesavings medicines.
Scientists have found that the more severely patients have been hit by depression across their lifespan, the less they react emotionally to negative faces during current depression.
John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary Zeus Acquisition Corporation, a cash tender offer to purchase all outstanding shares of common stock of ZymoGenetics, Inc.. Bristol-Myers Squibb announced on Tuesday, September 7, 2010 its intent to acquire ZymoGenetics.
› Verified 9 days ago
| Entity Name | Monroe County Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811027576 PECOS PAC ID: 2668365859 Enrollment ID: O20040203000319 |
News Archive
Marking the start of Antibiotic Awareness Week, NPS MedicineWise is urging all health professionals to pledge their commitment to preserve the miracle of antibiotics and re-shape consumer expectations of these lifesavings medicines.
Scientists have found that the more severely patients have been hit by depression across their lifespan, the less they react emotionally to negative faces during current depression.
John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary Zeus Acquisition Corporation, a cash tender offer to purchase all outstanding shares of common stock of ZymoGenetics, Inc.. Bristol-Myers Squibb announced on Tuesday, September 7, 2010 its intent to acquire ZymoGenetics.
› Verified 9 days ago
| Entity Name | Gulf Health Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134164924 PECOS PAC ID: 3375448491 Enrollment ID: O20110208000622 |
News Archive
Marking the start of Antibiotic Awareness Week, NPS MedicineWise is urging all health professionals to pledge their commitment to preserve the miracle of antibiotics and re-shape consumer expectations of these lifesavings medicines.
Scientists have found that the more severely patients have been hit by depression across their lifespan, the less they react emotionally to negative faces during current depression.
John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary Zeus Acquisition Corporation, a cash tender offer to purchase all outstanding shares of common stock of ZymoGenetics, Inc.. Bristol-Myers Squibb announced on Tuesday, September 7, 2010 its intent to acquire ZymoGenetics.
› Verified 9 days ago
| Entity Name | Imc North Baldwin Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619473766 PECOS PAC ID: 8426307729 Enrollment ID: O20180820003389 |
News Archive
Marking the start of Antibiotic Awareness Week, NPS MedicineWise is urging all health professionals to pledge their commitment to preserve the miracle of antibiotics and re-shape consumer expectations of these lifesavings medicines.
Scientists have found that the more severely patients have been hit by depression across their lifespan, the less they react emotionally to negative faces during current depression.
John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary Zeus Acquisition Corporation, a cash tender offer to purchase all outstanding shares of common stock of ZymoGenetics, Inc.. Bristol-Myers Squibb announced on Tuesday, September 7, 2010 its intent to acquire ZymoGenetics.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George E Fahy Iii, MD 2004 Medical Center Dr, Bay Minette, AL 36507-4163 Ph: (251) 937-2380 | Dr George E Fahy Iii, MD 2004 Medical Center Dr, Bay Minette, AL 36507-4163 Ph: (251) 937-2380 |
News Archive
Marking the start of Antibiotic Awareness Week, NPS MedicineWise is urging all health professionals to pledge their commitment to preserve the miracle of antibiotics and re-shape consumer expectations of these lifesavings medicines.
Scientists have found that the more severely patients have been hit by depression across their lifespan, the less they react emotionally to negative faces during current depression.
John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary Zeus Acquisition Corporation, a cash tender offer to purchase all outstanding shares of common stock of ZymoGenetics, Inc.. Bristol-Myers Squibb announced on Tuesday, September 7, 2010 its intent to acquire ZymoGenetics.
› Verified 9 days ago
Dr. Marla Jean Gleason, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Center Dr, Bay Minette, AL 36507 Phone: 251-937-7016 Fax: 251-937-7612 |